Gene therapy with angiogenic factors: A new potential approach to the treatment of ischemic diseases

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 9, 1997, Pages 2311-2325

  Safi Jr , Jorge ^a   Gloe, Torsten R ^a   Riccioni, Teresa ^a,b   Kovesdi, Imre ^c   Capogrossi, Maurizio C ^a,b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c GENVEC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; GENE THERAPY; GENE TRANSFER; ISCHEMIA; PRIORITY JOURNAL; REVIEW;

EID: 0031238657     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0459     Document Type: Review

References (128)

1. ARMENTANO D, SOOKDEO CC, HEHIR KM, GREGORY RJ, ST. GEORGE GA, PRINCE GA, WADSWORTH SC, SMITH AE, 1995. Characterization of an adenovirus gene transfer vector containing an E4 deletion. Hum Gene Ther 6: 1343-1353.
2. ASAHARA T, BAUTERS C, ZHENG LP, TAKESHITA S, BUNTING S, FERRARA N, SYMES JF, ISNER JM, 1995. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92 Suppl. II): 365-371.
3. BAFFOUR R, BERMAN J, GARB JL, RHEE SW, KAUFMAN J, FRIEDMANN P, 1992. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 16: 181-91.
4. BANAI S, JAKLITSCH MT, CASSCELLS W, SHRIVASTAV S, CORREA R, EPSTEIN SE, UNGER EF, 1991. Effects of acidic fibroblast growth factor on normal and ischemic myocardium. Circ Res 69: 76-85.
5. BANAI S, SHWEIKI A, PINSON A, CHANDRA M, LAZAROVICI G, KESHET E, 1994a. Upregulation of vascular endothelial growth factor expression induced by myocardial ischemia: implications for coronary angiogenesis. Cardiovasc Res 28: 1176-1179.
6. BANAI S, JAKLITSCH MT, SHOU M, LAZAROUS DF, SCHEINOWITZ M, BIRO S, EPSTEIN SE, UNGER EF, 1994b. Angiogenic-induced enhancement of collateral blood flow to ischemicmyocardium by vascular endothelial growth factor in dogs. Circulation 89: 2183-2189.
7. BARLEON B, HAUSER S, SCHOLLMANN C, WEINDEL K, MAZME D, YAYON D, WEICH HA, 1994. Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells. J Cell Biochem 54: 56-66.
8. BASILICO C, MOSCATELLI D, 1992. The FGF family of growth factors oncogenes. Adv Cancer Res 59: 115-165.
9. BAUTERS C, ASAHARA T, ZHENG LP, TAKESHITA S, BUNTING S, FERRARA N, SYMES JF, ISNER JM, 1995. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg 21: 314-325.
10. BREIER G, ALBRECHT U, STERRER S, RISAU W, 1992. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial differentiation. Development 114: 521-532.
11. BROUGH DE, LIZONOVA A, HSU C, KULESA VA, KOVESDI I, 1996. A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. J Virol 70: 6497-6501.
12. BURGESS WH, DIONNE CA, KAPLOW J, MUDD R, FRIESEL R, ZILBERSTEIN A, SCHLESSINGER J, JAYE M, 1990. Characterization and cDNA cloning of phospholipase C-gamma a major substrate for heparin-binding growth factor 1 (acidic fibroblast growth factor) activated tyrosine kinase. Mol Cell Biol 10: 4770-4777.
13. CAPOGROSSI MC, PASSANITI A, 1997. Angiogenesis in the lung. In: Crystal RG, West JB, Weibel ER, Barnes PJ (eds). The Lung. Scientific Foundations 2nd ed. New York: Raven Press, 2629-2645.
14. CHLEBOUN JO, MARTINS RN, MITCHELL CA, CHRILLA TV, 1992. Basic FGF enhances the development of the collateral circulation after acute arterial occlusion. Biochem Biophys Res Com 185: 510-516.
15. CONE RD, MULLIGAN RC, 1984. High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host gene. Proc Natl Acad Sci USA 81: 6349-6353.
16. D'AMORE PA, 1992. Capillary growth: a two cell system. Sem Cancer Biol 3: 49-56.
17. DEMENEIX BA, ABDEL TAWEB H, BENOIST C, SEIGNET I, BEHR JP, 1994. Temporal and spatial expression of lipospermine compacted genes transferred into chick embryos in vivo. Biotechniques 16: 496-501.
18. DICKSON C, FULLER-PACE F, KIEFER P, ACLAND P, MACALLAN D, PETERS G, 1991. Expression, processing, and properties of int-2. Ann NY Acad Sci 638: 18-26.
19. ENGELHARDT JF, YE X, DORANZ B, WILSON JM, 1994a. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 91: 6196-6200.
20. ENGELHARDT JF, LITZKY L, WILSON JM, 1994b. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2 a. Hum Gene Ther 5: 1217-1229.
21. FAN TP, JAGGAR R, BICKNELL R, 1995. Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends Pharmacol Sci 16: 57-66.
22. FARHOOD H, GAO X, SON K, YANG YY, LAZO JS, HUANG L, BARSOUM J, BOTTEGA R, EPAND RM, 1994. Cationic liposomes for direct gene transfer in therapy of cancer and other diseases. Ann N Y Acad Sci 31: 23-34.
23. FELGNER PL, GADEK TR, HOLM M, ROMAN R, CHANG HW, WENZ M, NORTHROP JP, RINGOLD JM, DANIELSEN M, 1987. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 84: 7413-7417.
24. FERRARA N, WINER J, BURTON T, 1991. Aortic smooth muscle cells express and secret vascular endothelial growth factor. Growth Factors 5: 141-148.
25. FOLKMAN J, 1971. Tumor angiogenesis: therapeutic implications. N Engl J Med 223: 1296-1299.
26. FOLKMAN J, SHING Y, 1992. Angiogenesis. J Biol Chem 267: 10931-10934.
27. FOROUGH R, ZHAN X, MACPHEE M, FRIEDMAN S, ENGLEKA KA, SAYERS T, WILTROUT RH, MACIAG T, 1993. Differential transforming abilities of non-secreted forms of human fibroblast growth factor-2. J Biol Chem 268: 2960-2968.
28. v integrins. Science 270: 1500-1502.
29. FRIESEL RE, MACIAG T, 1995. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J 9: 919-925.
30. FRUH K, AHN K, DJABALLAH H, SEMPE P, VAN ENDERT PM, TAMPE R, PETERSON PA, YANG Y, 1995. A viral inhibitor of peptide transporters for antigen. Nature 375: 415-418.
31. FUJITA M, SASAYAMA S, ASANOI H, NAKAJIMA H, SAKAI O, OHNO A, 1988. Improvement of treadmill capacity and collateral circulation as a result of exercise with heparin pretreatment in patients with effort angina. Circulation 77: 1022-1029.
32. GAY CG, WINKLES JA, 1990. Heparin-binding growth factor-1 stimulation of human endothelial cells induces platelet-derived growth factor α-chain gene expression. J Biol Chem 265: 3284-3292.
33. GIORDANO FL, PING P, MCKIRNAN D, NOZAKI S, DEMARIA A, DILLMANN WH, MATHIEU-COSTELLO O, HAMMOND HK, 1996. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat Med 2: 534-539.
34. GIVOL D, YAYON A, 1992. Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J 6: 3362-3369.
35. GOLDFARB M, BATES B, DRUCKER B, HARDIN J, HAUB O, 1991. Expression and possible functions of the FGF-5 gene. Ann N Y Acad Sci 638: 38-52.
36. GOODING LR, WOLD WS, 1990. Molecular mechanisms by which adenoviruses counteract antiviral immune defenses. Crit Rev Immunol 10: 53-71.
37. GORZIGLIA MI, KADAN MJ, YEI S, LEE GM, LUTHRA R, TRAPNELL BC, 1996. Elimination of both E1 and E2a from adenovirus vectors further improves prospects for in vivo human gene therapy. J Virol 70: 4173-4178.
38. GOSPODAROWICZ D, CHENG J, 1986. Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 128: 475-484.
39. GOTO F, GOTO K, WEINDEL K, FOLKMAN J, 1993. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cell within collagen gels. Lab Invest 69: 508-517.
40. GUALANDRIS A, URBINATI C, RUSNATI M, ZICHE M, PRESTA M, 1994. Interaction of high-molecular-weight basic fibroblast growth factor with endothelium: biological activity and intracellular fate of human recombinant M(r) 24,000 bFGF. J Cell Physiol 161: 149-159.
41. HARADA K, GROSSMAN W, FRIEDMAN M, EDELMAN ER, PRASAD PV, KEIGHLEY CS, MANNING WJ, SELLKE FW, SIMONS M, 1994. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest 94: 623-630.
42. HASHIMOTO E, OGITA T, NAKAOKA T, MATSUOKA R, TAKAO A, KIRAY, 1994. Rapid induction of vascular endothelial growth factor expression by transient ischemia in the rat heart. Am J Physiol 267: H1948-H1954.
43. HENRY LJ, XIA D, WILKE ME, DEISENHOFER J, GERARD RD, 1994. Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli J Virol 68: 5239-5246.
44. HILL A, JUGOVIC P, YORK I, RUSS G, BENNINK J, YEWDELL J, PLOEGH H, JOHNSON D, 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375: 411-415.
45. HIRAI T, FUJITA M, NAKAJIMA H, ASANOI H, YAMANISHI K, OHNO A, SASAYAMA S, 1989. Importance of collateral circulation for prevention of left ventricular aneurysm formation in acute myocardial infarction. Circulation 79: 791-796.
46. HORRIGAN MC, MACISAAC AI, NICOLINI FA, VINCE DG, LEE P, ELLIS SG, TOPOL EJ, 1996. Reduction in myocardial infarct size by basic fibroblast growth factor after temporary coronary occlusion in a canine model. Circulation 94: 1927-1933.
47. HORWITZ MS, 1990. Adenoviridae and their replication. In: Fields BN, Knipe KN, Chanockal RN (eds). Virology. New York: Raven Press, 1679-1721.
48. HUDLICKA O, BROWN M, EGGINTON S, 1992. Angiogenesis in skeletal and cardiac muscle. Physiol Rev 72: 369-364.
49. IIDA S, YOSHIDA T, NAITO K, SAKAMOTO H, KATOH O, HIROHASHI S, SATO T, ONDA M, SUGIMURA T, TERADA M, 1992. Human hst-2 (FGF-6) oncogene: cDNA cloning and characterization. Oncogene 7: 303-309.
50. ISNER JM, WALSHK, SYMES J, PIECZEK A, TAKESHITA S, LOWRY J, ROSSOW S, ROSENFIELD K, WEIR LE, 1995. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation 91: 2687-2692.
51. ISNER JM, PIECZEK A, SCHAINFELD R, BLAIR R, HALEY L, ASAHARA T, ROSENFIELD K, RAZVI S, WALSH K, SYMES JF, 1996a. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 348: 370-374.
52. JACKSON A, FRIEDMAN S, ZHAN X, ENGLEKA KA, FOROUGH R, MACIAG T, 1992. Heat shock induces the release of fibroblast growth factor-1 from NIH3T3 cells. Proc Natl Acad Sci USA 89: 10691-10695.
53. KANDEL J, BOSSY-WETZEL E, RADVANYI F, KLAGSBRUN M, FOLKMAN J, HANAHAN D, 1991. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66: 1095-1104.
54. KROUGLIAK V, GRAHAM FL, 1995. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants. Hum Gene Ther 6: 1575-1586.
55. LADOUX A, FRELIN C, 1993. Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem Biophys Res Com 195: 1005-1010.
56. LAZAROUS DF, SCHEINOWITZ M, SHOU M, HODGE E, RAJANAYAGAM S, HUNSBERGER S, ROBISON WG JR, STIBER JA, CORREA R, EPSTEIN SE, UNGER EF, 1995. Effects of chronic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 91: 145-153.
57. LAZAROUS DF, SHOU M, SCHEINOWITZ M, HODGE E, THIRUMURTI V, KITSIU AN, STIBER JA, LOBO AD, HUNSBERGER S, GUETTA E, EPSTEIN SE, UNGER EF, 1996. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 94: 1074-1082.
58. LEE MG, ABINA MA, HADADA H, PERRICAUDET M, 1995. The constitutive expression of the immunomodulatory gp 19k protein in E1-, E3-adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector. Gene Ther 2: 256-262.
59. LEGENDRE JY, SZOKA FC JR, 1993. Cyclic amphipathic peptide DNA complexes mediate high efficiency transfection of adherent mammalian cells. Proc Natl Acad Sci USA 90: 893-897.
60. LEVY AP, LEVY NS, LOSCALZO J, CALDERONE A, TAKAHASHI N, YEO KT, KOREN G, COLUCCI WS, GOLDBERG MA, 1995. Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res 76: 758-766.
61. LI J, BROWN LF, HIBBERD MG, GROSSMAN JD, MORGAN JP, SIMONS M, 1996. VEGF, flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol 270: H1803-H1811.
62. LORENZI MV, LONG JE, MIKI T, AARONSON SA, 1995. Expression cloning, developmental expression, and chromosomal localization of fibroblast growth factor-8. Oncogene 10: 2051-2055.
63. MANNARINO E, PASQUALINI L, INNOCENTE S, ORLANDI U, SCRICCIOLO V, LOMBARDINI R, CIUFETTI G, 1991. Efficacy of low-molecular-weight heparin in the management of intermittent claudication. Angiology 42: 1-7.
64. MERWIN JR, NOELL GS, THOMAS WL, CHIOU HC, DEROME ME, MCKEE TD, SPITALNY GL, FINDERS MA, 1994. Targeted delivery of DNA using YEE (GaINAcAH)3, a synthetic glycopeptide ligand for the glycoprotein receptor. Bioconjug Chem 5: 612-620.
65. MESRI EA, FEDEROFF HJ, BROWNLEE M, 1995. Expression of vascular endothelial growth factor from a defective Herpes simplex virus type 1 amplicom vector induces angiogenesis in mice. Circ Res 76: 161-167.
66. MIDDLETON PG, CAPLEN NJ, GAO X, HUANG L, GAYA H, GEDDES DM, ALTON EW, 1994. Nasal application of the cationic liposome DC-Chol: DOPE does not alter ion transport, lung function or bacterial growth. Eur Respir J 7: 442-445.
67. MILLER DG, ADAM MA, MILLER AD, 1990. Gene transfer by retrovirus occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10: 4239-4242.
68. MIYAMOTO M, NARUO K, SEKO C, MATSUMOTO S, KONDO T, KUROKAWA T, 1993. Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property. Mol Cell Biol 13: 4251-4259.
69. MORISHITA R, GIBBONS GH, KANEDA Y, OGIHARA T, DZAU VJ, 1993. Novel in vitro gene transfer method for study of local modulators in vascular smooth muscle cells. Hypertension 21: 894-899.
70. MORISHITA R, GIBBONS GH, KANEDA Y, OGIHARA T, DZAU VJ, 1994. Pharmacokinetics of antisense oligodeoxy-ribonucleotides (cyclin Bl and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery. Gene 149: 13-19.
71. MÜHLHAUSER J, PILI R, MERRILL MJ, MAEDA H, PASSANITI A, CRYSTAL RG, CAPOGROSSI MC, 1995a. In vivo angiogenesis induced by recombinant adenovirus vectors coding either for secreted or non-secreted forms of acidic fibroblast growth factor. Hum Gene Ther 6: 1457-1465.
72. 165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo. Circ Res 77: 1077-1086.
73. NABEL GJ, NABEL EG, YANG ZY, FOX BA, PLAUTZ GE, GAO X, HUANG L, SHU S, GORDON D, CHANG AE, 1993. Direct gene transfer with DNA liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in human. Proc Natl Acad Sci USA 90: 11307-11311.
74. NAMIKI A, BROGIE, KEARNEYM, KIMEA, WU T, COUFFINHAL T, VARTICOVSKIL, ISNER JM, 1995. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 270: 31189-31195.
75. v integrins in adenovirus infection. In: Preissner KT, Rosenblatt S, Kost C, Wegerhoff J, Mosher DF (eds). Biology of vitronectins and their receptors. Amsterdam, The Netherlands: Elsevier Science Publishers, 177-184.
76. PASSANITI A, TAYLOR RM, PILI R, GUO Y, LONG PV, HANEY JA, PAULY RR, GRANT DS, MARTIN GR, 1992. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest 67: 519-528.
77. PEPPER MS, FERRARA N, ORCI L, MONTESANO R, 1992. Potent synergism between vascular endothelial growth factor and fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Com 189: 824-831.
78. PHILIPSON L, LONBERG-HOLM K, PETTERSON U, 1968. Virus-receptor interaction in an adenovirus system. J Virol 2: 1064-1075.
79. PILI R, CHANG J, MÜHLHAUSER J, BEWING B, CRYSTAL RG, CAPOGROSSI MC, PASSANITI A, 1997. Adenovirus-mediated gene transfer of angiogenic growth factors and biosafety: lack of increased tumorigenicity in vivo. Int J Cancer (in press).
80. PLAUTZ GE, YANG ZY, WU BY, GAO X, HUANG L, NABEL GJ, 1993. Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc Natl Acad Sci USA 90: 4645-4649.
81. PU LQ, SNIDERMANN AD, BRASSARD R, LACHAPELLE KJ, GRAHAM AM, LISBONA R, SYMES JF, 1993. Enhanced revascularization of the ischemic limb by angiogenic therapy. Circulation 88: 208-215.
82. PUYAL C, MILHAUD P, BIENVENUE A, PHILIPPOT JR, 1995. A new cationic liposome encapsulating genetic material: a potential delivery system for polynucleotides. Eur J Biochem 228: 697-703.
83. RAWLE FC, TOLLEFSON AE, WOLD WS, GOODING LR, 1989. Mouse anti-adenovirus cytotoxic T lymphocytes. Inhibition of lysis by E3 gp19K but not E3 14.7K. J Immunol 143: 2031-2037.
84. REILAND J, RAPRAEGER AC, 1993. Heparan sulfate proteoglycan and FGF receptor target basic FGF to different intracellular destinations. J Cell Sci 105: 1085-1093.
85. REMY JS, SIRLIN C, VIERLING P, BEHR JP, 1994. Gene transfer with a series of lipophilic DNA binding molecules. Bioconjug Chem 5: 647-654.
86. RIESSEN R, RAHIMIZADEH H, BLESSING E, TAKESHITA S, BARRY JJ, ISNER JM, 1993. Arterial gene transfer using pure DNA applied directly to a hydrogel coated angioplasty balloon. Hum Gen Ther 4: 749-758.
87. ROGHANI M, MOSCATELLI D, 1992. Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J Biol Chem 67: 22156-22162.
88. ROSENGART TK, JOHNSON WV, FRIESEL R, CLARK R, MACIAG T, 1988. Heparin protects heparin-binding growth factor-I from proteolytic inactivation in vitro. Biochem Biophys Res Com 152: 432-440.
89. RUBIN JS, BOTTARO DP, CHEDID M, MIKI T, RON D, CHEONG G, TAYLOR WG, FORTNEY E, SAKATA H, FINCH PW, 1995. Keratinocyte growth factor. Cell Biol Int 19: 399-411.
90. 2 activity. J Biol Chem 269: 3219-3225.
91. SAFI J JR, GLOE TR, DIPAULA AF JR, BECKER LC, CAPOGROSSI MC, 1996. Adenovirus-mediated gene transfer of acidic fibroblast growth factor reduces the risk region in a rabbit model of myocardial infarction (Abstract). Circulation 94 (Suppl.): I-590-I-591.
92. SAN H, YANG ZY, POMPILI VJ, JAFFE ML, PLAUTZ GE, XU L, FELGENER JH, WHEELER CJ, FELGENER PL, GAO X, 1993. Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy. Hum Gene Ther 4: 781-788.
93. SCHLESSINGER J, LAX I, LEMMON M, 1995. Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? Cell 83: 357-360.
94. SHEPRO D, MOREL NM, 1993. Pericyte physiology. FASEB J 7: 1031-1038.
95. SHIBUYA M, YAMAGUCHI S, YAMANE A, IKEDA T, TOJO A, MATSUSHIME H, SATOM, 1990. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5: 519-524.
96. SHWEIKI D, ITIN A, SOFFER D, KESHET E, 1992. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845.
97. SOMMER A, RIFKIN DB, 1989. Interaction of heparin with human basic fibroblast growth factor: protection of the angiogenic protein from degradation by a glycosaminoglycan. J Cell Physiol 138: 215-220.
98. TAKESHITA S, ZHENG LP, BROGI E, KEARNEY M, PU LQ, BUNTING S, FERRARA N, SYMES JF, ISNER JM, 1994a. Therapeutic angiogenesis: a single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 93: 662-670.
99. TAKESHITA S, PU LQ, STEIN LA, SNIDERMAN AD, BUNTING S, FERRARA N, ISNER JM, SYMES JF, 1994b. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 90 (Suppl. II): II228-II234.
100. TAKESHITA S, WEIR L, CHEN D, ZHENG LP, RIESSEN R, BAUTERS C, SYMES JF, FERRARA N, ISNER JM, 1996a. Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochem Biophys Res Com 227: 628-635.
101. Takeshita S, Tsurumi Y, Couffinahl T, Asahara T, Bauters C, Symes J, Ferrara N, Isner JM, 1996b. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest 75: 487-501.
102. TERMAN BI, CARRION ME, KOVACS E, RASMUSSEN BA, EDDY RL, SHOWS TB, 1991. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6: 1677-1683.
103. THOMAS KA, 1996. Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 271: 603-606.
104. THOMPSON JA, ANDERSON KD, DIPIETRO JM, ZWIEBEL JA, ZAMETTA M, ANDERSON NF, MACIAG T, 1988. Site-directed neovessel formation in vivo. Science 241: 1349-1352.
105. TSURUMI Y, TAKESHITA S, CHEN D, KEARNEY M, ROSSOW ST, PASSERI J, HOROWITZ JR, SYMES JF, ISNER JM, 1996. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 94: 3281-3290.
106. UNGER EF, SHEFFIELD CD, EPSTEIN SE, 1991. Heparin promotes the formation of extracardiac to coronary anastomoses in a canine model. Am J Physiol 260: H1625-H1634.
107. UNGER EF, SHOU M, SHEFFIELD CD, HODGE E, JAYE M, EPSTEIN SE, 1993. Extracardiac to coronary anastomoses support regional left ventricular function in dogs. Am J Physiol 1264: H1567-H1574.
108. UNGER EF, BANAI S, SHOU M, LAZAROUS DF, JAKLITSCH MT, SCHEINOWITZ M, CORREA R, KLINGBEIL C, EPSTEIN SE, 1994. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 266: H1588-H1595.
109. VARGA MJ, WEIBULL C, EVERITT E, 1991. Infectious entry pathway of adenovirus type 2. J Virol 65: 6061-6070.
110. VLODAVSKY I, BAR-SHAVIT R, ISHAI-MICHAELI R, BASHKIN P, FUKS Z, 1991. Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem Sci 16: 268-271.
111. WALTENBERGER J, MAYR U, PENTZ S, HOMBACH V, 1996. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation 94: 1647-1654.
112. WANG Q, JIA XC, FINER MH, 1995. A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions. Gene Ther 2: 775-783.
113. WARE J, SIMONS M, 1997. Angiogenesis in ischemic heart disease. Nat Med 3: 158-164.
114. 5 promote adenovirus internalization but not virus attachment. Cell 73: 309-319.
115. 5 selectively promotes adenovirus mediated cell membrane permeability. J Cell Biol 127: 257-264.
116. WICKHAM TJ, CARRION ME, KOVESDI I, 1995. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther 10: 750-756.
117. WICKHAM TJ, ROELVINK PW, BROUGH DE, KOVESDI I, 1996a. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nat Biotech 14: 1570-1573.
118. WICKHAM TJ, SEGAL DM, ROELVINK PW, CARRION ME, LIZONOVA A, LEE GM, KOVESDI I, 1996b. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispeciflc antibodies. J Virol 70: 6831-6838.
119. YANAGISAWA-MIWA A, UCHIDA Y, NAKAMURA F, TOMARU T, KIDO H, KAMIJO T, SUGIMOTO T, KAJI K, UTSUYAMA M, KURASHIMA C, ITO H, 1992. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257: 1401-1403.
120. YANG HT, OGILVIE RW, TERJUNG RL, 1995. Heparin increases exercise-induced collateral blood flow in rats with femoral artery ligation. Circ Res 76: 448-456.
121. YANG Y, ERTL HC, WILSON JM, 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens. Immunity 1: 433-442.
122. YANG Y, LI Q, ERTL HCJ, WILSON JM, 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 69: 2004-2015.
123. YAYON A, KLAGSBRUN M, ESKO JD, LEDER P, ORNITZ DM, 1991. Cell surface heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64: 841-848.
124. YEH P, DEDIEU JF, ORSINI C, VIGNE E, DENEFLE P, PERRICAUDET M, 1996. Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. J Virol 70: 559-565.
125. YORK IA, ROOP C, ANDREWS DW, RIDDELL SR, GRAHAM FL, JOHNSON DC, 1994. A cytosolic herpes simplex virus protein inhibits antigen. Cell 77: 525-535.
126. YOSHIDA T, SAKAMOTO H, MIYAGAWA K, SUGIMURA T, TERADAM, 1991. Characterization of the hst-1 gene and its product. Ann N Y Acad Sci 638: 27-37.
127. YOSHIMURA K, ROSENFIELD MA, SETH P, CRYSTAL RG, 1993. Adenovirus mediated augmentation of cell transfection with unmodified plasmid vectors. J Biol Chem 268: 2300-2303.
128. ZHOU H, O'NEAL W, MORRAL N, BEAUDET AL, 1996. Development of a complementing cell line and a system for costruction of adenovirus vectors with E1 and E2a deleted. J Virol 70: 7030-7038.